Remote Jobs at REGENXBIO
Find your next remote opportunity · 3 Open Positions
REGENXBIO is a leading clinical-stage biotechnology company seeking to improve lives through the curative potential of gene therapy.
Since its founding in 2009, REGENXBIO has pioneered the development of AAV Therapeutics, an innovative class of gene therapy medicines.
REGENXBIO is advancing a pipeline of AAV Therapeutics for retinal and rare diseases, including ABBV-RGX-314 for the treatment of wet AMD and diabetic retinopathy, being developed in collaboration with AbbVie, RGX-202 for the treatment of Duchenne and RGX-121 for the treatment of MPS II.
Thousands of patients have been treated with REGENXBIO’s AAV Therapeutic platform, including Novartis’ ZOLGENSMA for children with spinal muscular atrophy.
Designed to be one-time treatments, AAV Therapeutics have the potential to change the way healthcare is delivered for millions of people.
Market Development Director – Central Region
Market Development Director driving regional launch readiness for REGENXBIO’s rare and neuromuscular disease gene therapies. Leading treatment-center engagement, market access, and commercial strategy across the Central U.S.
Market Development Director – Northeast Region
Market Development Director advancing REGENXBIO’s rare-disease gene therapy launches. Driving regional strategy, treatment-center engagement, market access, and commercial readiness.
Market Development Director – West Region
Market Development Director advancing REGENXBIO’s rare and neuromuscular disease gene therapy launches. Driving regional stakeholder engagement, treatment access, and commercial readiness across the West Region.
No more jobs available.